共 209 条
[1]
Nekhlyudov L(2017)Going beyond being lost in transition: a decade of Progress in Cancer survivorship J Clin Oncol 35 1978-1981
[2]
Ganz PA(2015)The expanding role of primary care in cancer control Lancet Oncol 16 1231-1272
[3]
Arora NK(2012)The basis for monitoring strategies in clinical guidelines: a case study of prostate-specific antigen for monitoring in prostate cancer CMAJ 184 169-177
[4]
Rowland JH(2014)American Cancer Society prostate cancer survivorship care guidelines CA Cancer J Clin 64 225-249
[5]
Rubin G(2010)Impact of biochemical recurrence in prostate cancer among US veterans Arch Intern Med 170 1390-1395
[6]
Berendsen A(2013)Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions Clin Adv Hematol Oncol 11 14-23
[7]
Crawford SM(2016)Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up BJU Int 117 10-19
[8]
Dommett R(2014)The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors Urology 84 300-306
[9]
Earle C(2013)Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 436-445
[10]
Emery J(2017)Quality of life outcomes after primary treatment for clinically localised prostate Cancer: a systematic review Eur Urol 72 869-885